M
M M Hou
Researcher at University of Oxford
Publications - 1
Citations - 986
M M Hou is an academic researcher from University of Oxford. The author has contributed to research in topics: Randomized controlled trial. The author has an hindex of 1, co-authored 1 publications receiving 555 citations.
Papers
More filters
Journal ArticleDOI
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
M N Ramasamy,Angela M. Minassian,Katie J. Ewer,Amy Flaxman,P M Folegatti,Daniel R Owens,Merryn Voysey,Parvinder K. Aley,Brian Angus,G Babbage,Sandra Belij-Rammerstorfer,L Berry,S Bibi,M Bittaye,Katrina Cathie,H Chappell,Sue Charlton,P Cicconi,Elizabeth A. Clutterbuck,R Colin-Jones,Christina Dold,Emary Krw.,Sofiya Fedosyuk,Michelle Fuskova,Diane Gbesemete,Christopher A Green,Bassam Hallis,M M Hou,D Jenkin,Joe Ccd.,Elizabeth J. Kelly,S Kerridge,Alison M. Lawrie,A Lelliott,May Nwe Lwin,R Makinson,N G Marchevsky,Y Mujadidi,Munro Aps.,M Pacurar,E Plested,J Rand,Thomas A. Rawlinson,S Rhead,Hannah Robinson,Adam J. Ritchie,A L Ross-Russell,Stephen Saich,Nisha Singh,Catherine C. Smith,Matthew D. Snape,R Song,R Tarrant,Yrene Themistocleous,Kelly M. Thomas,Tonya Villafana,Sarah Warren,Watson Mee.,Alexander D. Douglas,Hill Avs.,Teresa Lambe,Sarah C. Gilbert,Saul N. Faust,Andrew J. Pollard +63 more
TL;DR: The specific objectives of this report were to assess the safety and humoral and cellular immunogenicity of a single-dose and two-dose schedule in adults older than 55 years, and safety, as measured by the occurrence of serious adverse events.